Elite Pharmaceuticals Inc (ELTP)

[Couch]

Quote:
What do you suppose those .44 cent shares are worth

Judging by the way the savvy ELTP shareholders are now selling I would say less than 29¢.

This says otherwise. Eli 200 is coming and so is $2. Next

The pivotal trial met its primary endpoint (p = 0.001), demonstrating statistical significance that the product provided pain relief following surgery in the treatment group using ELI-200 compared to the placebo group. Secondary endpoint results were consistent with primary findings and included safety measures. There were no serious adverse events or deaths related to ELI-200 reported during the conduct of the trial.